PRMT3 drives PD-L1-mediated immune escape through activating PDHK1-regulated glycolysis in hepatocellular carcinoma
Abstract Aberrant expression of programmed death ligand-1 (PD-L1) facilitates tumor immune evasion. Protein arginine methyltransferase 3 (PRMT3), a member of type I PRMT family, mediates asymmetric dimethylarginine (ADMA) modification of various substrate proteins. This study investigates the role o...
Saved in:
| Main Authors: | Chen-Hong Ding, Fang-Zhi Yan, Bo-Nan Xu, Hui Qian, Xia-Lu Hong, Shu-Qing Liu, Yuan-Yuan Luo, Si-Han Wu, Ling-Yan Cai, Xin Zhang, Wei-Fen Xie |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2025-03-01
|
| Series: | Cell Death and Disease |
| Online Access: | https://doi.org/10.1038/s41419-025-07482-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PRMT1 promotes immune escape in hepatocellular carcinoma by regulating arginine methylation modification of MYC protein
by: Han Zhou, et al.
Published: (2025-12-01) -
LMNB2-mediated high PD-L1 transcription triggers the immune escape of hepatocellular carcinoma
by: Yuxuan Li, et al.
Published: (2025-06-01) -
PRMT1‐mediated arginine methylation promotes YAP activation and hepatocellular carcinoma proliferation
by: Jian Yu, et al.
Published: (2024-12-01) -
Tumor-associated bacteria activate PRDX1-driven glycolysis to promote immune evasion and PD-1 antibody resistance in hepatocellular carcinoma
by: Heng Zhang, et al.
Published: (2025-07-01) -
PRMT6 Epigenetically Drives Metabolic Switch from Fatty Acid Oxidation toward Glycolysis and Promotes Osteoclast Differentiation During Osteoporosis
by: Wenxiang Chu, et al.
Published: (2024-10-01)